DRUG · Mapped RxNorm record
Insulin glulisine
Normalized identity: insulin glulisine, humanView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
NCT00607087
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Insulin lispro
Normalized identity: insulin lisproView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Insulin aspart
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetes Mellitus, Type 1unresolved
Interventions
Insulin glulisineDRUG · verified · RxNorm: insulin glulisine, human
Insulin lisproDRUG · verified · RxNorm: insulin lispro
Insulin aspartDRUG
Sponsors & collaborators
Sanofilead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00607087 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.